Cardiol Therapeutics Inc (CRDL) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cardiol Therapeutics inc   (NASDAQ: CRDL)


Cardiol Therapeutics Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cardiol Therapeutics Inc's ROI in the fourth quarter of 2025?
Cardiol Therapeutics Inc recorded a cumulative net loss of $-26 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -190.52%.

Within the Healthcare sector 851 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 4899.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -26.88 % -25.54 % -21.54 % -17.8 % -14.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 14 14 14 17
Return On Investment (TTM) -190.52 % -191.93 % -176.06 % -162.62 % -151.08 %
CRDL's Overall Ranking # 4899 # # # # 5065
Seq. Investment Change TTM -7.11 % -8.27 % -7.64 % -7.09 % -5.4 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -26 -28 -28 -28 -28

CRDL Company Profile >> Back to CRDL Roi Comparisons >> See Annual CRDL Return On Investment



Return On Investment CRDL's Ranking
Within: No.
Industry # 135
Sector # 852
Overall # 4899

Return On Investment Statistics
High Average Low
-61.64 %
-124.59 %
-184.75 %
(Dec 31 2022)   (Dec 31 2025)







Financial Statements
Cardiol Therapeutics Inc's IV. Quarter Investments $ 13 Millions CRDL's Balance sheet
Cardiol Therapeutics Inc's IV. Quarter Income $ -26 Millions Quarterly CRDL's Income Statement
CRDL's Income by Division See CRDL's Income by Division


CRDL Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2020)
2021
Total Investments in Millions 13 17 22 39 60
Y / Y Investment Growth -24.11 % -19.74 % -44.25 % -35.41 % -
Net Income in Millions -24 -27 -21 -24 -25
Y / Y Net Income Growth - - - - -
Annual Return On Investment -184.75 % -155.09 % -96.89 % -61.64 % -42.26 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CRDL's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CRDL's Competitors
Subscribers only: Roi for Cardiol Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CRDL's Customers

Other Ratios
CRDL's Roa CRDL's Inventory Turnover Ratio CRDL's Growth Rates CRDL's Dividend Statistics
CRDL's Profitability Ratios CRDL's Asset Turnover Ratio CRDL's Dividend Growth
CRDL's Roe CRDL's Valuation Ratios CRDL's Financial Strength Ratios CRDL's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T10:06:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.